Past News

Do you have experience in chemical hazard classification and Safety Data Sheet (SDS) requirements? Are you detail-oriented and able to work under pressure and meet deadlines? Do you have the excellent written and oral communication skills required to gather and provide technical information to users? Would you like to contribute to the activities of an International Organisation working for human...

CEP holders are requested to consult the list of substances for which draft revised monographs of the European Pharmacopoeia (Ph. Eur.) have been published in Pharmeuropa 33.3.

A new draft monograph, Golimumab concentrated solution (3103), has been published in this quarter’s issue of Pharmeuropa (33.3), the European Pharmacopoeia (Ph. Eur.) online forum for comment.

At its 170th plenary session on 22-23 June 2021, the European Pharmacopoeia Commission decided to suspend the Gonadotrophin, equine serum, for veterinary use (0719) monograph. This means that as of Supplement 10.8, the monograph in question will no longer be part of the Ph. Eur. but will nonetheless remain on the Ph. Eur. work programme until a final decision can be made concerning its fate.

The EDQM announces the availability of 9 new European Pharmacopoeia (Ph. Eur.) reference standards and 22 replacement batches for Ph. Eur. reference standards.

All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 33.3 is 30 September 2021.

The European Pharmacopoeia (Ph. Eur.) Commission held its 170th session on 22 and 23 June 2021. As the decision-making body of the Ph. Eur., the Commission adopted 69 texts that will be published in Ph. Eur. Supplement 10.8 and be effective as of 1 July 2022.